348: Cuts, ousters and drama at the FDA
The Readout Loud
00:00
Intro
The hosts examine the current challenges facing the biotech industry, including FDA changes and declining stock values, while also addressing the implications of new tariffs. Featuring insights from an FDA reporter and an interview with a pharma executive, the chapter explores strategies for resilience and growth amidst adversity.
Transcript
Play full episode
